GONADOTROPINS, ESTRADIOL, AND GROWTH-FACTORS REGULATE EPITHELIAL OVARIAN-CANCER CELL-GROWTH

被引:76
作者
WIMALASENA, J [1 ]
DOSTAL, R [1 ]
MEEHAN, D [1 ]
机构
[1] UNIV NEBRASKA,MED CTR,DEPT PHYSIOL & BIOPHYS,OMAHA,NE 68105
关键词
D O I
10.1016/0090-8258(92)90230-G
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Indirect evidence suggests that gonadal steroids and gonadotropins may have a role in the genesis of epithelial ovarian cancer. In the studies reported herein, we established 17β-estradiol (E2) secreting cell cultures from an omental metastasis of an epithelial ovarian cancer. We demonstrate that human chorionic gonadotropin (hCG), human follicle-stimulating hormone, and epidermal growth factor (EGF) increased cell growth in a dose- and time-dependent manner, whereas E2 inhibited cell growth in the nanomolar range. Epidermal growth factor was able to partially block the negative effect of E2; a similar but quantitatively lesser effect was observed with hCG. These results provide direct evidence to support the view that gonadotropins, EGF, TGFβ (transforming growth factor), and estradiol may modulate growth of metastatic epithelial ovarian cancer cells. © 1992.
引用
收藏
页码:345 / 350
页数:6
相关论文
共 21 条
[1]   OCCURRENCE OF EPIDERMAL GROWTH-FACTOR RECEPTORS IN HUMAN ADNEXAL TUMORS AND THEIR PROGNOSTIC VALUE IN ADVANCED OVARIAN CARCINOMAS [J].
BAUKNECHT, T ;
RUNGE, M ;
SCHWALL, M ;
PFLEIDERER, A .
GYNECOLOGIC ONCOLOGY, 1988, 29 (02) :147-157
[2]   CLINICAL-SIGNIFICANCE OF ONCOGENES AND GROWTH-FACTORS IN OVARIAN CARCINOMAS [J].
BAUKNECHT, T ;
BIRMELIN, G ;
KOMMOSS, F .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1990, 37 (06) :855-862
[3]   EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION IN NORMAL OVARIAN EPITHELIUM AND OVARIAN-CANCER .1. CORRELATION OF RECEPTOR EXPRESSION WITH PROGNOSTIC FACTORS IN PATIENTS WITH OVARIAN-CANCER [J].
BERCHUCK, A ;
RODRIGUEZ, GC ;
KAMEL, A ;
DODGE, RK ;
SOPER, JT ;
CLARKEPEARSON, DL ;
BAST, RC .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1991, 164 (02) :669-674
[4]  
BERCHUCK A, 1990, OBSTET GYNECOL, V75, P255
[5]  
CRAMER DW, 1983, JNCI-J NATL CANCER I, V71, P717
[6]   MENOPAUSE AND OVARIAN-CANCER [J].
HARTGE, P ;
HOOVER, R ;
MCGOWAN, L ;
LESHER, L ;
NORRIS, HJ .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1988, 127 (05) :990-998
[7]   SOME OBSERVATIONS ON THE EFFECT OF A GNRH ANALOG IN OVARIAN-CANCER [J].
JAGER, W ;
WILDT, L ;
LANG, N .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1989, 32 (02) :137-148
[8]   LEUPROLIDE ACETATE IN THE TREATMENT OF REFRACTORY OR PERSISTENT EPITHELIAL OVARIAN-CANCER [J].
KAVANAGH, JJ ;
ROBERTS, W ;
TOWNSEND, P ;
HEWITT, S .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (01) :115-118
[9]  
MCGOWAN L, 1989, ONCOLOGY, V46, P51
[10]  
NASH JD, 1989, OBSTET GYNECOL, V73, P1009